ProPhase Labs to Present at the 2025 ThinkEquity Conference
ProPhase Labs (NASDAQ: PRPH) will participate in the ThinkEquity Conference on October 30, 2025 at the Mandarin Oriental Hotel in New York.
Ted Karkus, CEO and Chairman, will present at 11:00 AM ET on October 30 and will hold one-on-one investor meetings throughout the day. Interested investors can register and schedule meetings via the provided registration link, and the presentation will be live-streamed at the supplied webcast URL.
ProPhase Labs (NASDAQ: PRPH) parteciperà al ThinkEquity Conference il 30 ottobre 2025 presso l'hotel Mandarin Oriental a New York.
Ted Karkus, CEO e Presidente, terrà la presentazione alle 11:00 AM ET del 30 ottobre e terrà incontri one-to-one con gli investitori durante tutta la giornata. Gli investitori interessati possono registrarsi e fissare gli incontri tramite il link di registrazione fornito, e la presentazione sarà trasmessa in diretta sul URL webcast fornito.
ProPhase Labs (NASDAQ: PRPH) participará en la ThinkEquity Conference el 30 de octubre de 2025 en el Mandarin Oriental Hotel de Nueva York.
Ted Karkus, CEO y Presidente, presentará a las 11:00 AM ET el 30 de octubre y mantendrá reuniones individuales con inversores durante todo el día. Los inversores interesados pueden registrarse y programar reuniones a través del enlace de registro proporcionado, y la presentación será transmitida en vivo en la URL de webcast suministrada.
ProPhase Labs (NASDAQ: PRPH)은 ThinkEquity Conference에 뉴욕의 Mandarin Oriental Hotel에서 2025년 10월 30일에 참가합니다.
Ted Karkus, CEO 겸 Chairman,는 10월 30일 동부 표준시 ET 11:00에 발표할 예정이며 하루 종일 투자자와의 1대1 미팅을 진행합니다. 관심 있는 투자자는 제공된 등록 링크를 통해 등록하고 회의를 예약할 수 있으며, 발표는 실시간 스트리밍으로 제공된 웹캐스트 URL에서 시청될 것입니다.
ProPhase Labs (NASDAQ: PRPH) participera à la ThinkEquity Conference le 30 octobre 2025 à l'hôtel Mandarin Oriental à New York.
Ted Karkus, PDG et Président, présentera à 11:00 AM ET le 30 octobre et mènera des réunions individuelles avec les investisseurs tout au long de la journée. Les investisseurs intéressés peuvent s'inscrire et programmer des réunions via le lien d'inscription fourni, et la présentation sera diffusée en direct à l'URL du webcast fournie.
ProPhase Labs (NASDAQ: PRPH) wird am ThinkEquity Conference am 30. Oktober 2025 im Mandarin Oriental Hotel in New York teilnehmen.
Ted Karkus, CEO und Chairman, wird am 11:00 Uhr ET am 30. Oktober präsentieren und den ganzen Tag lang One-on-One-Investorengespräche führen. Interessierte Investoren können sich über den bereitgestellten Registrierungslink anmelden und Treffen planen, und die Präsentation wird live gestreamt unter der angegebenen Webcast-URL.
ProPhase Labs (NASDAQ: PRPH) ستشارك في مؤتمر ThinkEquity Conference في 30 أكتوبر 2025 بفندق Mandarin Oriental في نيويورك.
سيقدم تيد كاركوس، الرئيس التنفيذي ورئيس مجلس الإدارة، في 11:00 صباحًا بتوقيت شرق الولايات المتحدة في 30 أكتوبر وسيعقد لقاءات فردية مع المستثمرين طوال اليوم. يمكن للمستثمرين المهتمين التسجيل وجدولة الاجتماعات عبر رابط التسجيل المقدم، كما ستُذاع العرض بثًا مباشرًا على عنوان البث المقدم.
- None.
- None.
UNIONDALE, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced that it will be participating in the ThinkEquity Conference on October 30, 2025, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies.
Ted Karkus, CEO and Chairman of the Board of Directors, will be presenting at 11AM ET on October 30th. One-on-one investor meetings will be held throughout the day. Interested investors can register to attend and schedule one-on-one meetings here: https://www.meetmax.com/sched/event_121867/conference_home.html
The presentation will also be live-streamed at the following link:
https://event.summitcast.com/view/NX3WagbdCmRzBGMxdc3ia6/guest_book?session_id=PDgxE2V2WRZcL6RynfToZv
About ProPhase Labs Inc.
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our mission is to build a healthier world through bold innovation and actionable insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, groundbreaking diagnostic development, such as our potentially life-saving test for the early detection of esophageal cancer, and a world class direct-to-consumer marketing platform for cutting edge OTC dietary supplements. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value. www.ProPhaseLabs.com
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman: jboidman@renmarkfinancial.com
Tel.: (416) 644-2020 or (212) 812-7680
www.renmarkfinancial.com
FAQ
When will ProPhase Labs (PRPH) present at the ThinkEquity Conference?
How can investors register for ProPhase Labs (PRPH) one-on-one meetings on October 30, 2025?
Will ProPhase Labs (PRPH) provide a webcast of its ThinkEquity Conference presentation?
Who is presenting for ProPhase Labs (PRPH) at the October 30, 2025 ThinkEquity Conference?
Where is the ThinkEquity Conference on October 30, 2025 taking place for ProPhase Labs (PRPH)?
